175 related articles for article (PubMed ID: 34579929)
41. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT.
Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M
J Photochem Photobiol B; 2006 Jan; 82(1):1-8. PubMed ID: 16203156
[TBL] [Abstract][Full Text] [Related]
42. Effects of hypericin encapsulated on Pluronic F127 photodynamic therapy against triple negative breast cancer.
De Souza MVF; Shinobu-Mesquita CS; Meirelles LEF; Mari NL; César GB; Gonçalves RS; Caetano W; Damke E; Silva VR; Damke GM; Consolaro MEL
Asian Pac J Cancer Prev; 2022 May; 23(5):1741-1751. PubMed ID: 35633560
[TBL] [Abstract][Full Text] [Related]
43. Biodistribution and photodynamic therapy with hypericin in a human NPC murine tumor model.
Du HY; Bay BH; Olivo M
Int J Oncol; 2003 May; 22(5):1019-24. PubMed ID: 12684667
[TBL] [Abstract][Full Text] [Related]
44. Hypericin-mediated photodynamic antimicrobial effect on clinically isolated pathogens.
Yow CM; Tang HM; Chu ES; Huang Z
Photochem Photobiol; 2012; 88(3):626-32. PubMed ID: 22233203
[TBL] [Abstract][Full Text] [Related]
45. Topically applied hypericin exhibits skin penetrability on nude mice.
Li ZH; Li YY; Hou M; Yang T; Lu LC; Xu XY
Lasers Med Sci; 2018 Aug; 33(6):1279-1286. PubMed ID: 29915976
[TBL] [Abstract][Full Text] [Related]
46. Bio-distribution and subcellular localization of Hypericin and its role in PDT induced apoptosis in cancer cells.
Ali SM; Olivo M
Int J Oncol; 2002 Sep; 21(3):531-40. PubMed ID: 12168096
[TBL] [Abstract][Full Text] [Related]
47. Hypericin Accumulation as a Determinant of PDT Efficacy.
Kessel D
Photochem Photobiol; 2020 Sep; 96(5):1144-1147. PubMed ID: 32599667
[TBL] [Abstract][Full Text] [Related]
48. In vitro study of the photocytotoxicity of bathochromically-shifted hypericin derivatives.
Roelants M; Lackner B; Waser M; Falk H; Agostinis P; Van Poppel H; de Witte PA
Photochem Photobiol Sci; 2009 Jun; 8(6):822-9. PubMed ID: 19492110
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of calcium phosphate nanostructures by combustion in solution as a potential encapsulant system of drugs with photodynamic properties for the treatment of cutaneous leishmaniasis.
Lopera AA; Montoya A; Vélez ID; Robledo SM; Garcia CP
Photodiagnosis Photodyn Ther; 2018 Mar; 21():138-146. PubMed ID: 29198762
[TBL] [Abstract][Full Text] [Related]
50. Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells.
Thomas C; Pardini RS
Photochem Photobiol; 1992 Jun; 55(6):831-7. PubMed ID: 1409890
[TBL] [Abstract][Full Text] [Related]
51. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
Kamuhabwa AA; Huygens A; De Witte PA
Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
[TBL] [Abstract][Full Text] [Related]
52. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
Jendzelovský R; Mikes J; Koval' J; Soucek K; Procházková J; Kello M; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
Photochem Photobiol Sci; 2009 Dec; 8(12):1716-23. PubMed ID: 20024169
[TBL] [Abstract][Full Text] [Related]
53. ROS-responsive dexamethasone micelles normalize the tumor microenvironment enhancing hypericin in cancer photodynamic therapy.
Liang R; Wong KH; Yang Y; Duan Y; Chen M
Biomater Sci; 2022 Feb; 10(4):1018-1025. PubMed ID: 35023512
[TBL] [Abstract][Full Text] [Related]
54. Antivascular tumor eradication by hypericin-mediated photodynamic therapy.
Chen B; Roskams T; de Witte PA
Photochem Photobiol; 2002 Nov; 76(5):509-13. PubMed ID: 12462645
[TBL] [Abstract][Full Text] [Related]
55. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
56. Hypericin-loaded lipid nanocapsules for photodynamic cancer therapy in vitro.
Barras A; Boussekey L; Courtade E; Boukherroub R
Nanoscale; 2013 Nov; 5(21):10562-72. PubMed ID: 24056802
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of photodynamic therapy using TiO
Sepúlveda AAL; Arenas Velásquez AM; Patiño Linares IA; de Almeida L; Fontana CR; Garcia C; Graminha MAS
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101676. PubMed ID: 32001331
[TBL] [Abstract][Full Text] [Related]
58. Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines.
Stupáková V; Varinská L; Mirossay A; Sarisský M; Mojzis J; Dankovcík R; Urdzík P; Ostró A; Mirossay L
Phytother Res; 2009 Jun; 23(6):827-32. PubMed ID: 19173218
[TBL] [Abstract][Full Text] [Related]
59. Plasmid DNA-Based Bioluminescence-Activated System for Photodynamic Therapy in Cancer Treatment.
Fan D; Wang T; Hu J; Zhou L; Zhou J; Wei S
ChemMedChem; 2021 Jun; 16(12):1967-1974. PubMed ID: 33594787
[TBL] [Abstract][Full Text] [Related]
60. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
